Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immuno-Biological Laboratories
Fujioka City, Chiba, Japanibl-japan.co.jp ↗
- Ownership
- Private
- Employees
- ~51
- Development stage
- Other
01
Overview
IBL supplies high-quality antibodies and research assays—especially ELISA kits—used globally for cancer, neurodegenerative, infectious, and metabolic disease research. Their transgenic silkworm technology enables production of advanced proteins and human collagen for both medical diagnostics and cosmetics.
- Therapeutic areas
- ImmunologyEndocrinologyInfectious DiseasesNeurologyOncology
- Modalities
- AntibodyProteinEnzymeRecombinant proteinELISA kitsChemiluminescent diagnostic tools
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
International diagnostic manufacturerspharmaceutical companies (licensees; names undisclosed)
Beyond the preview
Go deeper on Immuno-Biological Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immuno-Biological Laboratories.